$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
地拉罗司分散片哪里买的到?
2025-10-19 11:44:20
Check Details
地拉罗司分散片是什么药?
2025-10-19 11:44:20
Check Details
地拉罗司分散片一个疗程多少钱?
2025-10-19 11:44:20
Check Details
地拉罗司分散片功效与作用
2025-10-19 11:44:20
Check Details
地拉罗司分散片吃完多长时间见效?
2025-10-19 11:44:20
Check Details
地拉罗司分散片适应症
2025-10-19 11:44:20
Check Details
地拉罗司吃多久为一疗程
2025-10-19 11:44:20
Check Details
地拉罗司分散片是否纳入医保?地拉罗司进医保后多少钱?
2025-10-19 11:44:20
Check Details
【疗效跟踪】地拉罗司(Deferasirox)吃多长时间能见效?
2025-10-19 11:44:20
Check Details
地拉罗司进医保后多少钱一盒?地拉罗司医保后价格仍然偏贵?
2025-10-19 11:44:20
Check Details
【去铁效果】地拉罗司(恩瑞格)对长期输血铁“超载”疗效如何?
2025-10-19 11:44:20
Check Details
你最想了解的,地拉罗司怎么服用,地拉罗司的用法用量
2025-10-19 11:44:20
Check Details
1
2
...
47
48
49
50
51
52
53
...
937
938
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights
2
Revumenib Mechanism Explained: Targeting menin-KMT2A Interaction to Reshape Leukemia Cell Fate
3
Asciminib (Scemblix): Targeted Mechanism, Dosing Regimens, and Missed-Dose Guidance
4
Gilteritinib (XOSPATA): Dosing Cycle, Treatment Duration, and Development Background
5
Long-Term Anagrelide Use: Common Adverse Effects and Key Monitoring Considerations
6
Anagrelide vs. Hydroxyurea in Essential Thrombocythemia: Efficacy Profiles and Clinical Positioning
7
SCEMBLIX (Asciminib) Side Effect Management & Special Population Guide
8
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
9
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia
10
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
11
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
12
Tazemetostat: Mechanism, Standard Dosing, and the 2026 Global Withdrawal of the First-in-Class EZH2 Inhibitor